Towards Personalising the Use of Biologics in Rheumatoid Arthritis: A Discrete Choice Experiment.

Respondents were generally receptive to personalised medicine in RA, but researchers developing personalised approaches should pay close attention to generating evidence on both the PPV and the NPV of their technologies.